Corcept Therapeutics Incorporated (CORT)
Healthcare • Biotechnology
StockNasdaqCMUnited StatesUS2183521028
71.57 USD
-2.90% today Updated 13 Nov 2026 16:28
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Corcept Therapeutics Incorporated, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:28. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
24 Feb 2027
in 103 days · 16:00 · estimate 1.20
Last results
1.01 vs 0.84 estimated
03 Nov 2026 · Beat +20.2%
Beat the estimate
9 of 12
3 missed · 0 in line · 2 beats in a row
Average surprise
+46.0%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 24 Feb 2027 16:00 | 1.20 | — | — | Upcoming |
| 03 Nov 2026 16:00 | 0.84 | 1.01 | +20.2% | Beat |
| 29 Jul 2026 16:00 | 0.06 | 0.36 | +535.3% | Beat |
| 30 Apr 2026 16:00 | -0.14 | -0.30 | -111.3% | Miss |
| 24 Feb 2026 16:00 | 0.33 | 0.20 | -39.4% | Miss |
| 04 Nov 2025 16:00 | 0.14 | 0.16 | +18.5% | Beat |
| 31 Jul 2025 16:00 | 0.19 | 0.29 | +54.7% | Beat |
| 05 May 2025 16:00 | 0.14 | 0.17 | +19.3% | Beat |
| 26 Feb 2025 16:00 | 0.42 | 0.26 | -38.6% | Miss |
| 30 Oct 2024 16:00 | 0.29 | 0.41 | +41.4% | Beat |
| 29 Jul 2024 16:00 | 0.24 | 0.32 | +34.7% | Beat |
| 01 May 2024 16:00 | 0.22 | 0.25 | +13.6% | Beat |
| 15 Feb 2024 16:00 | 0.27 | 0.28 | +3.7% | Beat |
| 01 Nov 2023 16:00 | 0.23 | 0.28 | +21.7% | Beat |
| 02 Aug 2023 16:00 | 0.15 | 0.25 | +64.5% | Beat |
| 03 May 2023 16:00 | 0.21 | 0.14 | -32.7% | Miss |
| 28 Feb 2023 16:00 | 0.28 | 0.14 | -49.4% | Miss |
| 03 Nov 2022 16:00 | 0.28 | 0.30 | +7.1% | Beat |
| 03 Aug 2022 16:00 | 0.28 | 0.24 | -15.3% | Miss |
| 05 May 2022 16:00 | 0.31 | 0.20 | -35.5% | Miss |
| 15 Feb 2022 16:00 | 0.35 | 0.35 | 0.0% | In line |
| 03 Nov 2021 16:00 | 0.21 | 0.24 | +14.3% | Beat |
| 29 Jul 2021 16:00 | 0.17 | 0.30 | +81.8% | Beat |
| 06 May 2021 16:00 | 0.19 | 0.20 | +5.3% | Beat |
| 08 Feb 2021 16:00 | 0.17 | 0.27 | +58.8% | Beat |
| 03 Nov 2020 16:00 | 0.23 | 0.24 | +4.4% | Beat |
| 04 Aug 2020 16:00 | 0.21 | 0.32 | +52.4% | Beat |
| 04 May 2020 17:00 | 0.21 | 0.34 | +61.9% | Beat |
| 20 Feb 2020 16:00 | 0.26 | 0.33 | +26.9% | Beat |
| 07 Nov 2019 16:00 | 0.21 | 0.31 | +47.6% | Beat |
| 01 Aug 2019 16:00 | 0.19 | 0.25 | +31.6% | Beat |
| 09 May 2019 16:00 | 0.18 | 0.20 | +11.1% | Beat |
| 25 Feb 2019 16:00 | 0.21 | 0.24 | +12.5% | Beat |
| 01 Nov 2018 16:00 | 0.21 | 0.22 | +6.5% | Beat |
| 09 Aug 2018 16:00 | 0.24 | 0.20 | -16.7% | Miss |
| 08 May 2018 16:00 | 0.18 | 0.19 | +8.6% | Beat |
| 22 Feb 2018 16:00 | 0.17 | 0.77 | +346.4% | Beat |
| 02 Nov 2017 16:00 | 0.14 | 0.14 | 0.0% | In line |
| 01 Aug 2017 16:00 | 0.07 | 0.10 | +42.9% | Beat |
| 01 May 2017 16:00 | 0.03 | 0.04 | +33.3% | Beat |
| 30 Jan 2017 16:00 | 0.02 | 0.04 | +140.0% | Beat |
| 01 Nov 2016 16:00 | 0.01 | 0.02 | +100.0% | Beat |
| 02 Aug 2016 16:00 | 0.02 | 0.01 | -33.3% | Miss |
| 03 May 2016 16:00 | 0.01 | — | -100.0% | — |
| 01 Mar 2016 16:00 | — | 0.01 | — | — |
| 05 Nov 2015 16:00 | -0.02 | -0.01 | +50.0% | Beat |
| 05 Aug 2015 16:00 | -0.04 | -0.02 | +53.8% | Beat |
| 07 May 2015 11:00 | -0.05 | -0.05 | -7.1% | Miss |
| 04 Mar 2015 16:00 | -0.07 | -0.02 | +71.4% | Beat |
| 04 Nov 2014 16:00 | -0.07 | -0.06 | +9.1% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 761.4M | +12.8% | 99.7M | 13.1% | 0.82 | -33.3% | 141.8M |
| 2024 | 675M | +39.9% | 141.2M | 20.9% | 1.23 | +30.9% | 196.1M |
| 2023 | 482.4M | +20.0% | 106.1M | 22.0% | 0.94 | +8.0% | 126.5M |
| 2022 | 401.9M | — | 101.4M | 25.2% | 0.87 | — | 119.9M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 80.93 | 84.98 | 70.51 | 71.57 | -11.77% | 13,381,504 | |
| Oct 2026 | 114.29 | 122.81 | 80.28 | 81.12 | -29.60% | 20,479,300 | |
| Sep 2026 | 113.92 | 120.51 | 108.25 | 115.23 | +1.66% | 36,121,700 | |
| Aug 2026 | 114.16 | 126.38 | 107.32 | 113.35 | -1.00% | 18,238,300 | |
| Jul 2026 | 87.07 | 122.21 | 84.88 | 114.49 | +31.67% | 29,708,600 | |
| Jun 2026 | 69.29 | 89.24 | 68.25 | 86.95 | +25.13% | 21,161,400 | |
| May 2026 | 48.48 | 69.90 | 46.19 | 69.49 | +49.38% | 25,898,100 | |
| Apr 2026 | 40.61 | 47.29 | 40.36 | 46.52 | +15.41% | 22,248,000 | |
| Mar 2026 | 34.56 | 50.40 | 31.81 | 40.31 | +12.91% | 42,302,400 | |
| Feb 2026 | 39.87 | 42.26 | 28.66 | 35.70 | -10.46% | 37,692,800 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Can You Justify Buying Corcept Stock Today? (opens in a new tab) Trefis · 06 Nov 2026 12:20
- Corcept Therapeutics (CORT) Faces A Valuation Test As Profit Jumps And Pipeline Hopes Build (opens in a new tab) Simply Wall St. · 06 Nov 2026 06:13
- Corcept Therapeutics Incorporated Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 05 Nov 2026 01:42
- Corcept Therapeutics Inc (CORT) (Q3 2026) Earnings Call Highlights: Revenue Surges 64% as ... (opens in a new tab) GuruFocus.com · 04 Nov 2026 19:05
- Corcept Therapeutics (CORT) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 04 Nov 2026 15:45
- CORT's Q3 Earnings Beat, Higher Product Sales Aid Y/Y Revenues (opens in a new tab) Zacks · 04 Nov 2026 14:36
- Piper Sandler Reiterates Overweight on Corcept Therapeutics, Raises Price Target to $173 (opens in a new tab) Benzinga · 04 Nov 2026 13:21
- Corcept Therapeutics Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 04 Nov 2026 00:14
- Corcept Therapeutics (NASDAQ:CORT) Q3 EPS Beat Offset by In-Line Revenue and Reiterated Guidance (opens in a new tab) ChartMill · 03 Nov 2026 23:17
- Corcept Therapeutics falls on guidance despite earnings beat (opens in a new tab) Investing.com · 03 Nov 2026 22:20
- Corcept Therapeutics (CORT) Q3 Earnings and Revenues Surpass Estimates (opens in a new tab) Zacks · 03 Nov 2026 21:50
- Corcept’s (NASDAQ:CORT) Q3 2026: beats on revenue (opens in a new tab) StockStory · 03 Nov 2026 21:47
- Corcept: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 03 Nov 2026 21:31
- Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update (opens in a new tab) 03 Nov 2026 21:05
- Corcept Therapeutics Incorporated (CORT) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 03 Nov 2026 19:46
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 73.71 USD
- Market cap
- 8.1B
- Exchange
- NasdaqCM
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow CORT and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.